The two commonest, clinically well-defined, forms of parkinsonism are idiopathic Parkinson's disease (PD) and progressive supranuclear palsy (PSP). Both involve, inter alia, pathological changes in the substantia nigra pars compacta (SN(C)). In PD there is neuronal loss with associated Lewy body pathology and microglial activation. Three morphological features have been identified [Brain 114 (1991), 2283; Greenfield's Neuropathology 2 (1997), 289]. First, there is a gradient of pathological change such that the lateral segments are more affected than the medial. Second, there is thinning of the pigmented tissue, and third, there is a broadening of the overall structure in a dorsal-ventral direction, possibly caused by the migration of melanin-laden macrophages [Greenfield's Neuropathology 2 (1997), 289]. In contrast, PSP is characterized pathologically by intraneuronal neurofibrillary tangles. There are two morphological features in the SN(C) [Brain 114 (1991), 2283]. First, the gradient of pathological change is in the opposite direction to that of PD (i.e., the medial segments are more affected than the lateral). Second, there is atrophy. Any technique sensitive to neuropathology should be capable of detecting these features. We have previously reported on a new approach to detecting signal change in the substantia nigra in PD. This makes use of a ratio of images acquired by two distinct inversion recovery sequences [J. Neurol, Neurosurg. Psychiatry 67 (1999), 815; Am. J. Neuroradiol. 21 (2000) 697]. The prior work suggests that the technique is sensitive to, but not necessarily specific for, PD. We present here a preliminary report on an extension of the work. This is a semiautomated segmentation analysis that enables the substantia nigra to be displayed as an isolated structure. The technique is now given the acronym SIRRIM (segmented inversion recovery ratio imaging). In contrast to our earlier work, it allows for a more accurate assessment of the gross abnormalities. We report typical SIRRIM images of the SN(C). Images are shown for three subjects: a normal control, a patient with PD, and a "disease control" (a patient with PSP). In these examples all three morphological features of PD, as well as both morphological features of PSP, have radiological correlates. These preliminary findings suggest that SIRRIM may be specific for both diseases.
[1]
C. K. Yuen,et al.
Digital Filters
,
1979,
IEEE Transactions on Systems, Man, and Cybernetics.
[2]
J. MacQueen.
Some methods for classification and analysis of multivariate observations
,
1967
.
[3]
M Hutchinson,et al.
Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging.
,
2000,
AJNR. American journal of neuroradiology.
[4]
R. Ordidge,et al.
Assessment of relative brain iron concentrations using T2‐weighted and T2*‐weighted MRI at 3 Tesla
,
1994,
Magnetic resonance in medicine.
[5]
A. Lees,et al.
Ageing and Parkinson's disease: substantia nigra regional selectivity.
,
1991,
Brain : a journal of neurology.
[6]
P. Boesiger,et al.
T2 relaxation time in patients with Parkinson's disease
,
1993,
Neurology.
[7]
Craig Scott.
Introduction to Optics and Optical Imaging
,
1997
.
[8]
R I Grossman,et al.
Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes
,
1989,
Neurology.
[9]
J. Sá,et al.
[Importance of magnetic resonance in Parkinson disease. An analytic study of the pars compacta].
,
1990,
Acta medica portuguesa.
[10]
R. Ordidge,et al.
Increased iron‐related MRI contrast in the substantia nigra in Parkinson's disease
,
1995,
Neurology.
[11]
K. Miyasaka,et al.
[Magnetic resonance imaging in Parkinson's disease--the evaluation of the width of pars compacta on T2 weighted image].
,
1992,
Rinshō shinkeigaku Clinical neurology.
[12]
G. Paulson,et al.
Magnetic resonance imaging in Parkinson's disease.
,
1990,
Archives of neurology.
[13]
R. Grossman,et al.
MR imaging of Parkinson disease with spin-echo and gradient-echo sequences.
,
1988,
AJR. American journal of roentgenology.
[14]
M Hutchinson,et al.
Parkinson's disease: a novel MRI method for determining structural changes in the substantia nigra
,
1999,
Journal of neurology, neurosurgery, and psychiatry.